These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36092518)

  • 1. Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center.
    Hajeri S; Alturkistany Y
    Saudi Dent J; 2022 Sep; 34(6):479-484. PubMed ID: 36092518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging antiresorptive medications and their potential implications for dental surgeries.
    Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D
    J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy.
    Al Abdullateef A; Alhareky MS
    Saudi Pharm J; 2020 Jun; 28(6):771-778. PubMed ID: 32550810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.
    Yanni A; Bouland C; Monteiro R; Rodriguez A; Loeb I; Javadian R; Dequanter D
    J Int Soc Prev Community Dent; 2022; 12(5):564-570. PubMed ID: 36532328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy.
    Laimer J; Hechenberger M; Müller D; Walch B; Kolk A; Schnabl D; Schomaker M; Bruckmoser E
    Future Oncol; 2021 Jul; 17(21):2705-2711. PubMed ID: 33880956
    [No Abstract]   [Full Text] [Related]  

  • 11. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.
    Acharya S; Patil V; Ravindranath V; Kudva A; Nikhil K
    J Med Life; 2022 Mar; 15(3):368-373. PubMed ID: 35449990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies.
    AlRowis R; Aldawood A; AlOtaibi M; Alnasser E; AlSaif I; Aljaber A; Natto Z
    Saudi Dent J; 2022 Mar; 34(3):202-210. PubMed ID: 35935720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it safe to place implants in patients at risk of MRONJ?
    Owen B; Bradley H
    Evid Based Dent; 2021 Jan; 22(3):108-109. PubMed ID: 34561663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and Dental Professions' Varying Levels of Awareness Regarding Medication-related Osteonecrosis of the Jaw in Saudi Arabia? A Cross-sectional Study.
    Aljohani MH; Aljohani AS; Aljohani RM; Alsharif WK; Nourwali I; Elsayed SA
    J Contemp Dent Pract; 2024 Jan; 25(1):62-67. PubMed ID: 38514433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model.
    Zhu WY; Yang WF; Wang L; Lan X; Tao ZY; Guo J; Xu J; Qin L; Su YX
    J Orthop Translat; 2023 Mar; 39():55-62. PubMed ID: 36721766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
    Wick A; Bankosegger P; Otto S; Hohlweg-Majert B; Steiner T; Probst F; Ristow O; Pautke C
    Clin Oral Investig; 2022 Mar; 26(3):2839-2852. PubMed ID: 34812959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications.
    Assari AS; Alanazi Y; Mubarak Algharbi E; Abuhabsha A; Alshammry B; Alzahrani A; Alduhaim A; Abuhaimed R
    Cureus; 2024 Jan; 16(1):e52896. PubMed ID: 38406100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.